Discontinued — last reported Q3 '18
Zscaler Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 2.2% to $27.54M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 278.4%, from $7.28M to $27.54M. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q1 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.50M | $2.49M | $2.81M | $2.81M | $1.41M | $1.41M | $2.43M | $1.16M | $1.16M | $11.12M | $7.22M | $7.28M | $7.28M | $28.15M | $27.54M |
| QoQ Change | — | -44.6% | +12.9% | +0.0% | -50.0% | +0.1% | +72.4% | -52.4% | +0.0% | +862.3% | -35.1% | +0.9% | +0.0% | +286.8% | -2.2% |
| YoY Change | — | — | — | -37.5% | -43.5% | -49.9% | -13.7% | -17.9% | -18.0% | +357.8% | +524.7% | +530.1% | -34.5% | +290.2% | +278.4% |